开发和测试用化学疗法治疗的狗的临床症状和生活质量的业主报告结果测量方法
Jenny Harris1, Katie Sutton1, Quentin Fournier2
1Faculty of Health and Medical Sciences, School of Health Sciences, University of Surrey, Guildford, UK.
Veterinary and comparative oncology
|November 7, 2025
概括
一个新的数字工具,狗癌症结果测量 (CAN-COM),有助于主人跟踪化学疗法对狗的副作用. 这一措施是可行的,可接受的家庭使用,改善犬癌患者的监测和护理.
科学领域:
- 兽医瘤学 兽医瘤学
- 狗的健康 狗的健康
- 数字健康工具 数字健康工具
背景情况:
- 癌症是老犬死亡的主要原因之一.
- 业主报告的结果对于监测狗的化疗副作用至关重要.
- 数字工具可以加强业主参与追踪犬癌症治疗.
研究的目的:
- 开发和测试一种原型数字测量仪,用于监测正在接受化疗的狗的临床症状和生活质量.
- 在家庭环境中评估业主报告的结果措施的可行性和可接受性.
- 改善兽医护理和决策在犬类瘤学.
主要方法:
- 快速的文献审查以确定现有的措施和限制.
- 根据既定的标准和专家意见生成项目.
- 与29名狗主人进行概念验证测试,使用21天的每日评估和每周调查,包括认知面试.
主要成果:
- 报告的坚持率很高 (平均每天21次,每周3次评估).
- 疲劳,多脂症和厌食症是常见的临床症状;狗经历了3个症状的中位数.
- 狗癌症结局测量 (CAN-COM) 证明了可行性,可接受性和良好的生活质量尺度的内部一致性 (克朗巴赫的α = 0.84).
结论:
- 该CAN-COM原型是可行的,可接受的主人监测狗在家中接受化疗.
- 这种数字工具可以改善对不良事件的监测,并支持兽医决策.
- 进一步完善和验证CAN-COM可以提高犬癌患者的福利.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


